Answers are grounded in this paper and cite their sources.
This article corrects: Adapting viral safety assurance strategies to continuous processing of biological products Volume 114, Issue 1, 21–32, Article first published online: 17 August 2016 DOI: 10.1002/bit.26060 This erratum is being published to correct the author list for the article listed in References: Klutz SL, Martin, Bramsiepe, Christian, Schembecker, Gerard. 2016. Continuous viral inactivation at low pH value in antibody manufacturing. Chem Eng Process 102:88–101. The correct author list that was originally intended for publication is provided below: Klutz S, Lobedann M, Bramsiepe C, Schembecker, G. 2016. Continuous viral inactivation at low pH value in antibody manufacturing. Chem Eng. Process 102:88–101.
No takes yet. Share an insight, caveat, or question.
Johnson et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: